e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Defect of pro-HGF activation by IPF fibroblasts
S. Marchand-Adam, A. Fabre, J. Marchal, P. Soler, H. Kataoka, M. Dehoux, M. Aubier, B. Crestani (Paris, France; Miyazaki, Japan)
Source:
Annual Congress 2005 - From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session:
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session type:
Thematic Poster Session
Number:
724
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Marchand-Adam, A. Fabre, J. Marchal, P. Soler, H. Kataoka, M. Dehoux, M. Aubier, B. Crestani (Paris, France; Miyazaki, Japan). Defect of pro-HGF activation by IPF fibroblasts. Eur Respir J 2005; 26: Suppl. 49, 724
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Effusions related to TB
Laboratory diagnosis of tuberculosis
Related content which might interest you:
Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2
Source: Eur Respir J 2003; 22: Suppl. 45, 8s
Year: 2003
IPF fibroblasts secrete low levels of KGF: involvement of the JNK pathway
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004
Nintedanib prevents IL-6-mediated secretion of CCL-18 in alternatively activated macrophages and transition of fibroblasts to myofibroblasts
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Nintedanib modulates fibrogenesis in activated fibroblasts
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Oral Presentation: The functional role of the Frizzled-8 receptor TGF-beta1-induced activation and extracellular matrix production in human lung fibroblasts
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Activation of TLR3 augments myofibroblasts differentiation and extracellular matrix production
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009
Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004
Alveolar macrophages activate STAT3 in epithelial cells via gp130 dependant steroid insensitive mechanism
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
PP233 – Crosstalk between lung fibroblasts and mast cells is modified by alveolar extracellular matrix and influences epithelial migration
Source: ERS Lung Science Conference 2021
Year: 2021
K
Ca
3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts
in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Human airway trypsin-like protease stimulates differentiation of fibroblasts to myofibroblasts in human bronchial fibroblasts in vitro
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Role of phosphatidylinositol-3-kinase (PI3K) in TGF-β-induced proliferation and differentiation of human lung fibroblasts into myofibroblasts
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Cell cycle regulation of IPF-derived lung fibroblasts is dependent on RhoA signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005
Migration of human COPD fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006
BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept